Ruffo Frank
SEC CIK 1654450 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | CFO | 201.9K | — | $217.0K | 4 | 2022-02-01 | 2022-03-10 |
Most active insiders at ACRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Leonard Braden Michael | 10% | — | $1.36M |
| 2 | Kolbeck Roland Wilhelm | CSO | — | — |
| 3 | Hall Jesse Wayne | Chief Medical Off | — | — |
| 4 | Davis Hugh M. | Pres, COO, Dir | — | — |
| 5 | Balthaser Kevin | CFO | — | — |
| 6 | Loerop James | Chief Business Off | — | — |
| 7 | Humphries William D. | Dir | — | — |
| 8 | Molineaux Christopher P. | Dir | — | — |
| 9 | Walker Neal | CEO, Dir | — | — |
| 10 | Mehra Anand | Dir | — | — |
Ruffo Frank made no open-market trades at ACRS in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-14 | 2022-03-10 | ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | CFO | S - Sale | $15.55 | -12.8K | 201.9K | -6% | -$199.4K | |
| DM | 2022-03-03 | 2022-03-01+ | ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | CFO | M - OptEx | — | +42.3K | 214.7K | +25% | — |
| 2022-02-11 | 2022-02-09 | ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | CFO | S - Sale | $12.66 | -1,388 | 172.4K | -0.8% | -$17.6K | |
| D | 2022-02-03 | 2022-02-01 | ACRS | Aclaris Therapeutics, Inc. | Ruffo Frank | CFO | M - OptEx | — | +3,875 | 173.7K | +2% | — |
Purchase Sale Sale after option exercise All abbreviations